All About Sarclisa (Isatuximab) #myeloma

All About Sarclisa (Isatuximab) #myeloma

ASCO 2024 Top 5 SARCLISA Isatuximab + VRd Phase 3 IMROZ Multiple Myeloma QuestionsПодробнее

ASCO 2024 Top 5 SARCLISA Isatuximab + VRd Phase 3 IMROZ Multiple Myeloma Questions

ASCO 2024 Phase 3 IMROZ Results Evaluating Sarclisa (Isatuximab) + VRd in Transplant-Ineligible NDMMПодробнее

ASCO 2024 Phase 3 IMROZ Results Evaluating Sarclisa (Isatuximab) + VRd in Transplant-Ineligible NDMM

SARCLISA (isatuximab-irfc)- multiple myelomaПодробнее

SARCLISA (isatuximab-irfc)- multiple myeloma

What does the FDA approval of Sarclisa® (isatuximab) mean for myeloma patients?Подробнее

What does the FDA approval of Sarclisa® (isatuximab) mean for myeloma patients?

Sarclisa (isatuximab): a newly approved drug for treatment of multiple myeloma/ plasma cell myelomaПодробнее

Sarclisa (isatuximab): a newly approved drug for treatment of multiple myeloma/ plasma cell myeloma